Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Alaunos Therapeutics, Inc. (TCRT) had Free Cash Flow per Share of $-0.88 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.05M |
|
-- |
|
-- |
|
$1.04M |
|
$-1.04M |
|
$-0.01M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
$-1.04M |
|
$-1.04M |
|
1.68M |
|
1.68M |
|
$-0.63 |
|
$-0.63 |
|
| Balance Sheet Financials | |
$3.74M |
|
-- |
|
$1.00M |
|
$4.74M |
|
$1.07M |
|
-- |
|
-- |
|
$1.07M |
|
$3.66M |
|
$3.66M |
|
$3.66M |
|
2.08M |
|
| Cash Flow Statement Financials | |
$-1.47M |
|
$0.00M |
|
$3.26M |
|
$1.09M |
|
$2.88M |
|
$1.79M |
|
$0.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.71% |
|
-28.71% |
|
-22.20% |
|
-28.71% |
|
$1.76 |
|
|
Free Cash Flow per Share |
$-0.88 |
$-0.88 |
|